Home 2020

Archives

series B equity financing, mile high

MHL Series B equity financing and global CPG partnerships

Here, we learn how Mile High Labs, a leading processor of hemp-derived cannabinoids, have raised Series B equity financing and are preparing for global CPG partnerships.
novel food

EU and UK compliance with the novel food application for CBD isolate

Christian Hendriksen, VP of International Expansion at Mile High Labs, illustrates how they are continuing compliance with the novel food application to ensure safe and effective cannabinoids can be available to all.
cbd quality and compliance, novel food application

Setting global standards for CBD quality and compliance

At Mile High Labs, we share a collective vision for global standards of CBD quality and compliance: Let’s discuss the Novel Food application process for the UK.

CBD in food and beverages

John Wallace, Managing Director at Mile High Labs International, Ltd. explores the market of CBD in food and beverages, including regulation.
cbd by the numbers

CBD by the numbers: Exciting new products on the market

John Wallace, Managing Director of Mile High Labs, International, shares with us why CBD continues to be one of the most exciting new products to hit the marketplace and focuses here on some significant numbers in the field.
brand-new industry

CBD: A brief introduction to a brand-new industry

Mile High Labs International Limited provides a brief introduction to a brand-new industry, CBD, a non-psychoactive cannabinoid.
cannabis report

Mile High Labs welcomes findings from cannabis report

Mile High Labs has announced support for the findings in a Centre for Medicinal Cannabis report.

Follow Us

Advertisements